Innovent Biologics Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	132,367	132,265	59,956	69,333	51,403	70,547
Market Cap Growth	33.30%	120.60%	-13.53%	34.88%	-27.14%	-38.71%
Enterprise Value	115,212	125,514	54,283	63,850	44,899	59,352
Last Close Price	76.15	76.25	36.60	42.75	33.50	48.25
PE Ratio	145.60	146.09	-	-	-	-
Forward PE	39.40	42.67	-	-	-	-
PS Ratio	9.12	9.11	5.98	10.14	9.98	13.46
PB Ratio	6.15	6.14	4.30	5.02	4.24	5.56
P/TBV Ratio	6.67	6.67	4.76	5.04	4.25	5.57
P/FCF Ratio	12.22	12.21	175.32	-	-	-
P/OCF Ratio	11.89	11.88	43.78	425.78	-	-
EV/Sales Ratio	7.94	8.65	5.41	9.34	8.72	11.33
EV/EBITDA Ratio	83.92	86.09	194.28	-	-	-
EV/EBIT Ratio	162.57	153.74	-	-	-	-
EV/FCF Ratio	10.64	11.59	158.73	-	-	-
Debt / Equity Ratio	0.14	0.14	0.22	0.29	0.30	0.24
Debt / EBITDA Ratio	2.12	2.12	9.62	-	-	-
Debt / FCF Ratio	0.29	0.29	8.81	-	-	-
Net Debt / Equity Ratio	-0.80	-0.80	-0.38	-0.59	-0.55	-0.63
Net Debt / EBITDA Ratio	-11.77	-11.77	-19.24	5.70	2.06	2.57
Net Debt / FCF Ratio	-1.58	-1.58	-15.72	7.56	2.11	2.11
Asset Turnover	0.44	0.44	0.45	0.33	0.27	0.30
Inventory Turnover	2.87	2.87	2.52	1.51	1.00	1.19
Quick Ratio	2.38	2.38	2.08	2.68	2.78	3.27
Current Ratio	2.63	2.63	2.35	3.00	3.29	3.79
Return on Equity (ROE)	5.01%	5.01%	-0.74%	-8.84%	-20.70%	-28.56%
Return on Assets (ROA)	1.56%	1.56%	-0.36%	-5.12%	-11.54%	-12.04%
Return on Invested Capital (ROIC)	18.05%	11.85%	-1.86%	-31.37%	-72.59%	-95.23%
Return on Capital Employed (ROCE)	2.50%	2.50%	-0.70%	-9.70%	-22.20%	-20.50%
Earnings Yield	0.68%	0.68%	-0.17%	-1.63%	-4.79%	-4.75%
FCF Yield	8.18%	8.19%	0.57%	-1.54%	-6.19%	-5.38%
Buyback Yield / Dilution	-6.98%	-6.98%	-4.35%	-4.67%	-2.37%	-7.27%